DNTH
Dianthus Therapeutics, Inc. · Healthcare
Chief Accounting Officer Edward Carr sold $2.0M of Dianthus Therapeutics, Inc.
Sold$2,027,646
$101.38Price
20,000Shares
−100%Stake
What DNTH did after the filing
- The stock from Mon, Sep 21 open, $95.95
- −8.1%
- S&P 500, same days
- +0.4%
9 of 30 trading days so far, to the Oct 2 close.
Traded Thu, Sep 17. Filed Fri, Sep 18, 4:36 PM ET, after the close. Returns use the Sep 21 open and the Oct 2 close. Not investment advice.